Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 235

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 235
---
,000 per annum for Mr. Stahel’s services (reduced from £50,000 with effect from October 1, 2017), and if engaged
for any additional days, a rate of £2,000 would be paid per full working day. For the fiscal year ended December 31, 2022, Biodexa
Ltd paid Chesyl £13,333.

The Consultancy Agreement
was terminated in connection with Mr. Stahel’s resignation from our Board of Directors on June 20, 2022.

Agreements with the CMS Parties

CMS License Agreement

For information regarding
the CMS License Agreement, see “Business—Commercial Agreements, Strategic Partnerships and Collaborations—CMS License Agreement.”

Relationship Agreement

On January 29, 2019, the Company,
Panmure Gordon (UK) Limited (our former nominated advisor), the CMS Stockholders and certain affiliates of the CMS Stockholders, entered
a Relationship Agreement, or the Relationship Agreement, in order to regulate our relationships with the CMS and its affiliated entities,
collectively the CMS Parties, and to limit their influence over our corporate actions and activities and the outcome of general matters
pertaining to the Company. The Relationship Agreement was effective from February 26, 2019. The Relationship Agreement was subsequently
amended on May 12, 2020 and April 15, 2022.

Pursuant to the terms of the
Relationship Agreement, the CMS Parties have agreed to (amongst other things):

| • | conduct all transactions with us on an arm’s length terms and on a normal commercial basis, including in accordance with the              
 related party rules set out in the AIM Rules and any other applicable laws, regulations and stock exchange rules, and only with the prior 
 approval of a majority of independent directors;                                                                                          |

| • | exercise their voting rights or other rights and powers so as to ensure that each member of their respective Groups is capable of         
 carrying on its business and making decisions independently of each of the CMS Parties (and any of their group companies and associates); 
 and                                                                                                                                       |

| • | abstain from voting in respect of any resolution concerning any contract, arrangement or transaction with a related party of each 
 of the CMS Parties (or any of their associates).                                                                                  |

We further agreed to conduct
all transactions, agreements and relationships (whether contractual or otherwise) with the CMS Parties (and any of their group companies
and associates) on arm’s length terms and on